The University of Chicago Header Logo

Connection

Mark Talamonti to Polymorphism, Genetic

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Polymorphism, Genetic.
Mark Talamonti
Connection Strength
0.084
Polymorphism, Genetic
  1. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. Br J Dermatol. 2013 Aug; 169(2):458-63.
    View in: PubMed
    Score: 0.084
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.